177 related articles for article (PubMed ID: 31856610)
1. Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1
Oh Y; Jang M; Cho H; Yang S; Im D; Moon H; Hah JM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):372-376. PubMed ID: 31856610
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1
Jang M; Oh Y; Cho H; Yang S; Moon H; Im D; Hah JM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131443
[TBL] [Abstract][Full Text] [Related]
3. Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors.
Dou X; Huang H; Jiang L; Zhu G; Jin H; Jiao N; Zhang L; Liu Z; Zhang L
Eur J Med Chem; 2020 Sep; 201():112445. PubMed ID: 32603981
[TBL] [Abstract][Full Text] [Related]
4. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
Dou X; Huang H; Li Y; Jiang L; Wang Y; Jin H; Jiao N; Zhang L; Zhang L; Liu Z
J Med Chem; 2019 Jul; 62(14):6645-6664. PubMed ID: 31268308
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons.
Jun J; Baek J; Yang S; Moon H; Kim H; Cho H; Hah JM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681742
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives.
Zheng K; Iqbal S; Hernandez P; Park H; LoGrasso PV; Feng Y
J Med Chem; 2014 Dec; 57(23):10013-30. PubMed ID: 25393557
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies of 1,2-diaryl-1H-benzimidazole derivatives as JNK3 inhibitors with protective effects in neuronal cells.
Kim MH; Ryu JS; Hah JM
Bioorg Med Chem Lett; 2013 Mar; 23(6):1639-42. PubMed ID: 23416008
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives.
Zhu WJ; Cui BW; Wang HM; Nan JX; Piao HR; Lian LH; Jin CH
Eur J Med Chem; 2019 Oct; 180():15-27. PubMed ID: 31299584
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects.
Kim MH; Lee J; Jung K; Kim M; Park YJ; Ahn H; Kwon YH; Hah JM
Bioorg Med Chem; 2013 Apr; 21(8):2271-2285. PubMed ID: 23498914
[TBL] [Abstract][Full Text] [Related]
11. Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors.
Jung H; Aman W; Hah JM
Bioorg Med Chem Lett; 2017 May; 27(10):2139-2143. PubMed ID: 28372912
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.
Abu Rabah RR; Sebastian A; Vunnam S; Sultan S; Tarazi H; Anbar HS; Shehata MK; Zaraei SO; Elgendy SM; Al Shamma SA; Omar HA; Al-Tel TH; El-Gamal MI
Bioorg Med Chem; 2022 Sep; 69():116894. PubMed ID: 35764033
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold.
Yin Y; Chen CJ; Yu RN; Shu L; Zhang TT; Zhang DY
Bioorg Med Chem; 2019 Apr; 27(8):1562-1576. PubMed ID: 30846405
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL
Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006
[TBL] [Abstract][Full Text] [Related]
15. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38.
Kamenecka T; Habel J; Duckett D; Chen W; Ling YY; Frackowiak B; Jiang R; Shin Y; Song X; LoGrasso P
J Biol Chem; 2009 May; 284(19):12853-61. PubMed ID: 19261605
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of 1-Benzyl-1H-pyrazole Derivatives as Receptor Interacting Protein 1 Kinase Inhibitors.
Zou C; Xiong Y; Huang LY; Song CL; Wu XA; Li LL; Yang SY
Chem Biol Drug Des; 2016 Apr; 87(4):569-74. PubMed ID: 26577270
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease.
Jun J; Yang S; Lee J; Moon H; Kim J; Jung H; Im D; Oh Y; Jang M; Cho H; Baek J; Kim H; Kang D; Bae H; Tak C; Hwang K; Kwon H; Kim H; Hah JM
Eur J Med Chem; 2023 Jan; 245(Pt 1):114894. PubMed ID: 36343411
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK).
Smith AL; Andrews KL; Beckmann H; Bellon SF; Beltran PJ; Booker S; Chen H; Chung YA; D'Angelo ND; Dao J; Dellamaggiore KR; Jaeckel P; Kendall R; Labitzke K; Long AM; Materna-Reichelt S; Mitchell P; Norman MH; Powers D; Rose M; Shaffer PL; Wu MM; Lipford JR
J Med Chem; 2015 Feb; 58(3):1426-41. PubMed ID: 25587754
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
